Search research articles
Contact Us
Filters
Showing results (81-90 of 114) with videos related to
Page
of 12
Sort By:
Surgery
|
December 1, 1990
The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors
H N Langstein, J A Norton, V Chiang, et al.
Gastroenterology
|
October 1, 1990
The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells
P N Maton, E E Lack, M J Collen, et al.
Scandinavian Journal of Gastroenterology
|
October 1, 1992
Stereologic investigations of human gastric mucosa. II. Oxyntic mucosa from patients with Zollinger-Ellison syndrome
H F Helander, K Rutgersson, K G Helander, et al.
The American Journal of Medicine
|
November 1, 1989
Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome
H Frucht, J M Howard, H A Stark, et al.
The American Journal of Physiology
|
July 1, 1989
Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists
S C Huang, L Zhang, H C Chiang, et al.
The American Journal of Medicine
|
October 24, 1986
Famotidine in the therapy of gastric hypersecretory states
R Vinayek, J M Howard, P N Maton, et al.
European Journal of Clinical Investigation
|
August 1, 1982
Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis
E A Fagan, R F Dyck, P N Maton, et al.
World Journal of Surgery
|
October 1, 1987
The use of high-resolution intraoperative ultrasound to localize gastrinomas: an initial report of a prospective study
D T Cromack, J A Norton, B Sigel, et al.
Digestive Diseases and Sciences
|
January 11, 1991
Helicobacter pylori and Zollinger-Ellison syndrome
Z A Saeed, D J Evans, D G Evans, et al.
Gastroenterology
|
March 1, 1992
Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome
J R Pisegna, J A Norton, G G Slimak, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 114) with videos related to
Sort By:
Page
of 12
Surgery
|
December 1, 1990
The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors
H N Langstein, J A Norton, V Chiang, et al.
Gastroenterology
|
October 1, 1990
The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells
P N Maton, E E Lack, M J Collen, et al.
Scandinavian Journal of Gastroenterology
|
October 1, 1992
Stereologic investigations of human gastric mucosa. II. Oxyntic mucosa from patients with Zollinger-Ellison syndrome
H F Helander, K Rutgersson, K G Helander, et al.
The American Journal of Medicine
|
November 1, 1989
Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome
H Frucht, J M Howard, H A Stark, et al.
The American Journal of Physiology
|
July 1, 1989
Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists
S C Huang, L Zhang, H C Chiang, et al.
The American Journal of Medicine
|
October 24, 1986
Famotidine in the therapy of gastric hypersecretory states
R Vinayek, J M Howard, P N Maton, et al.
European Journal of Clinical Investigation
|
August 1, 1982
Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis
E A Fagan, R F Dyck, P N Maton, et al.
World Journal of Surgery
|
October 1, 1987
The use of high-resolution intraoperative ultrasound to localize gastrinomas: an initial report of a prospective study
D T Cromack, J A Norton, B Sigel, et al.
Digestive Diseases and Sciences
|
January 11, 1991
Helicobacter pylori and Zollinger-Ellison syndrome
Z A Saeed, D J Evans, D G Evans, et al.
Gastroenterology
|
March 1, 1992
Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome
J R Pisegna, J A Norton, G G Slimak, et al.
Page
of 12